DLCL (5)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Trading in Rights Entitlements (REs) for DR Lalchandani Labs Limited permitted from February 04, 2026 to February 17, 2026 with rights issue … | |||||||||||||||
Trading in Rights Entitlements (REs) for DR Lalchandani Labs Limited permitted from February 04, 2026 to February 17, 2026 with rights issue open from February 04 to February 20, 2026.
| |||||||||||||||
Trading in Rights Entitlements (REs) for DR Lalchandani Labs Limited commences on February 04, 2026, with renunciation period ending … | |||||||||||||||
Trading in Rights Entitlements (REs) for DR Lalchandani Labs Limited commences on February 04, 2026, with renunciation period ending February 17, 2026.
| |||||||||||||||
Rights Entitlements (REs) for DR LALCHANDANI LABS LIMITED will be available for trading and renunciation from February 04, 2026 to February … | |||||||||||||||
Rights Entitlements (REs) for DR LALCHANDANI LABS LIMITED will be available for trading and renunciation from February 04, 2026 to February 17, 2026, with the Rights Issue opening from February 04 to February 20, 2026.
| |||||||||||||||
BSE announces commencement of trading in Rights Entitlements (REs) for DR LALCHANDANI LABS LIMITED from February 04, 2026 to February 17, … | |||||||||||||||
BSE announces commencement of trading in Rights Entitlements (REs) for DR LALCHANDANI LABS LIMITED from February 04, 2026 to February 17, 2026, with the Rights Issue open from February 04 to February 20, 2026.
| |||||||||||||||
Commencement of trading in Rights Entitlements (REs) for DR LALCHANDANI LABS LIMITED from February 04, 2026 to February 17, 2026. | |||||||||||||||
Commencement of trading in Rights Entitlements (REs) for DR LALCHANDANI LABS LIMITED from February 04, 2026 to February 17, 2026.
| |||||||||||||||